title: Is hydrophobia necessary for the hepatologist prescribing nonselective beta-blockers in cirrhosis?
authors.forename: Marco
authors.initials: M
authors.lastname: Senzolo
authors.forename: Elena
authors.initials: E
authors.lastname: Nadal
authors.forename: Evangelos
authors.initials: E
authors.lastname: Cholongitas
authors.forename: Andrew K
authors.initials: AK
authors.lastname: Burroughs
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D057927:Hydrophobic and Hydrophilic Interactions; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D010538:Peritonitis / Q000382:microbiology / Q000517:prevention & control; D011433:Propranolol / Q000627:therapeutic use*; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D011433:Propranolol